LANXESS starts operating independently
With sales of around EUR 6 billion and around 20,000 employees, of whom approx. 11,000 are in Germany, LANXESS will be one of the leading chemicals companies in Europe. And after the planned stock market flotation it will operate as an independent company with its own business model, thereby enabling it to react faster and more flexibly on the market.
Dr. Axel C. Heitmann, designated LANXESS CEO, is fully satisfied with the progress of the carve-out process so far. In just over half a year, the activities of Bayer Chemicals and Bayer MaterialScience transferred to LANXESS and parts of the service companies have been molded together to form a new organization. "What we have to do now is use our strengths to their full advantage so as to achieve a competitive result and to ensure LANXESS a smooth transition to becoming an independent company outside the Bayer Group," he said. "That's why it's still important to seize every single possibility for cutting costs and grasp every new market opportunity."
Despite a 2.1 percent decline in sales to EUR 1.478 billion (2.2 percent up in local currencies), the consolidated business results for LANXESS in 1Q 2004 showed a 5.4 percent improvement in EBITDA to EUR 136 million. Compared to 1Q 2003, the EBIT grew by EUR 58 million to EUR 75 million.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.